<VariationArchive VariationID="485" VariationName="NM_000317.3(PTS):c.163+696_163+750del" VariationType="Deletion" Accession="VCV000000485" Version="3" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-04" DateCreated="2016-10-23" MostRecentSubmission="2022-07-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="15524" VariationID="485">
      <GeneList>
        <Gene Symbol="PTS" FullName="6-pyruvoyltetrahydropterin synthase" GeneID="5805" HGNC_ID="HGNC:9689" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11q23.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="112226428" stop="112233973" display_start="112226428" display_stop="112233973" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="112097087" stop="112104695" display_start="112097087" display_stop="112104695" Strand="+" />
          </Location>
          <OMIM>612719</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000317.3(PTS):c.163+696_163+750del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11q22.3-q23.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="112229367" stop="112229421" display_start="112229367" display_stop="112229421" variantLength="55" Strand="+" positionVCF="112229366" referenceAlleleVCF="TGTAAAGCACTGATAAAGTTTTTTTTTGTTGTTGTTGTTTTTTTTTTTGAGATGGA" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="112100090" stop="112100144" display_start="112100090" display_stop="112100144" variantLength="55" positionVCF="112100089" referenceAlleleVCF="TGTAAAGCACTGATAAAGTTTTTTTTTGTTGTTGTTGTTTTTTTTTTTGAGATGGA" alternateAlleleVCF="T" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.112229369_112229423del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.112229369_112229423del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.112100092_112100146del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.112100092_112100146del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008743.1" sequenceAccession="NG_008743" sequenceVersion="1" change="g.8005_8059del">
            <Expression>NG_008743.1:g.8005_8059del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000317.3" sequenceAccession="NM_000317" sequenceVersion="3" change="c.163+696_163+750del" MANESelect="true">
            <Expression>NM_000317.3:c.163+696_163+750del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA339816" DB="ClinGen" />
        <XRef ID="nssv7487212" DB="dbVar" />
        <XRef ID="nsv1197585" DB="dbVar" />
        <XRef Type="Allelic variant" ID="612719.0010" DB="OMIM" />
        <XRef Type="rs" ID="1555198165" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 19280650 to determine the location of this allele on the current reference sequence.</Comment>
      <Comment DataSource="NCBI curation" Type="ConvertedByNCBI">PMID 19280650 mapped this deletion to L76259.1:g.3760_3816del57.</Comment>
      <Comment DataSource="NCBI curation" Type="public">55-nt genomic deletion from intron 2 of gene PTS.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000317.3(PTS):c.163+696_163+750del AND 6-Pyruvoyl-tetrahydrobiopterin synthase deficiency" Accession="RCV000000514" Version="6">
        <ClassifiedConditionList TraitSetID="132">
          <ClassifiedCondition DB="MedGen" ID="C0878676">6-Pyruvoyl-tetrahydrobiopterin synthase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-05-17" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-05-17" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2016-10-23" MostRecentSubmission="2022-07-17">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">19280650</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19823873</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21542064</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32651154</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">33234470</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">35140743</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="132" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5291" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">6-pyruvoyl-tetrahydropterin synthase deficiency</ElementValue>
                <XRef ID="6-Pyruvoyl-Tetrahydropterin+Synthase+Deficiency/55" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">6-Pyruvoyltetrahydropterin Synthase Deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hyperphenylalanemia, BH4-deficient, A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">PTS Deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hyperphenylalaninemia due to 6-pyruvoyl-tetrahydropterin synthase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPERPHENYLALANINEMIA, TETRAHYDROBIOPTERIN-DEFICIENT, DUE TO PTS DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="261640" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">BH4-deficient hyperphenylalaninemia A</ElementValue>
                <XRef ID="MONDO:0009863" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">6-Pyruvoyl-tetrahydrobiopterin synthase deficiency</ElementValue>
                <XRef ID="237914002" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HPABH4A</ElementValue>
                <XRef Type="MIM" ID="261640" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5682" />
                <XRef ID="5682" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Phenylalanine.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated Phenylalanine, Phenylalanine hydroxylase deficiency (PAH), 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Phenylalanine-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, PAH deficiency: Elevated Phenylalanine, 2022</CitationText>
              </Citation>
              <XRef ID="13" DB="Orphanet" />
              <XRef ID="238583" DB="Orphanet" />
              <XRef ID="C0878676" DB="MedGen" />
              <XRef ID="MONDO:0009863" DB="MONDO" />
              <XRef Type="MIM" ID="261640" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="20663" SubmissionDate="2016-10-21" DateLastUpdated="2016-10-23" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="612719.0010_HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A" title="PTS, 55-BP DEL, NT694_HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A" />
        <ClinVarAccession Accession="SCV000020663" DateUpdated="2016-10-23" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2009-05-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Meili et al. (2009) reported a patient with BH4-deficient hyperphenylalaninemia (261640) resulting from a mutation that created a pseudoexon in the PTS gene. They identified a heterozygous 55-bp deletion in intron 2 that removed the poly(T) tail of the right arm of the antisense Alu sequence bringing a favorable branch point sequence within proximity of the pseudoexon 3-prime splice site and removing an upstream AG dinucleotide required for the 3-prime splice site repression on normal alleles. They found a reduced amount of correctly spliced transcript and a longer cDNA containing 45 extra nucleotides from intron 2. These findings showed the flexibility of Alu repeats in shaping intron-exon structures. RT-PCR analysis of dermal fibroblasts showed both correctly spliced transcript and the larger cDNA fragment containing the pseudoexon.</Attribute>
              <Citation>
                <ID Source="PubMed">19280650</ID>
              </Citation>
              <XRef DB="OMIM" ID="261640" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PTS" />
          </GeneList>
          <Name>PTS, 55-BP DEL, NT694</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">55-BP DEL, NT694</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="612719.0010" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4987165" SubmissionDate="2022-07-15" DateLastUpdated="2022-07-17" DateCreated="2022-07-17">
        <ClinVarSubmissionID localKey="NM_000317.2:c.163+696_163+750del55|MedGen:C0878676" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002547969" DateUpdated="2022-07-17" DateCreated="2022-07-17" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19823873</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32651154</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21542064</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">35140743</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">33234470</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19280650</ID>
          </Citation>
          <Comment>Variant summary: PTS c.163+696_163+750del55 is located at a deep intronic position not widely known to affect splicing. Several computational tools predict a significant impact on normal splicing: four predict the variant abolishes a cryptic 3' acceptor site, while four predict the variant strengthens a cryptic 3' acceptor site. The variant was absent in 150906 control chromosomes (gnomAD v3.1, genomes dataset). The variant c.163+696_163+750del55 (aka g.3760_3816del55) has been reported in the literature in individuals affected with 6-Pyruvoyl-Tetrahydropterin Synthase Deficiency, who carried a pathogenic variant in trans (Meili_2009, Manti_2020, Manzoni_2020). These data indicate that the variant may be associated with disease. Publications also reported experimental evidence, and generation of a pseudoexon was demonstrated from patient derived mRNA and in mini-gene assay systems (Meili_2009, Brasil_2011), together with the absence of protein product in patient derived fibroblasts (Meili_2009). No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PTS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000317.2:c.163+696_163+750del55</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0878676" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11800792</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="20663" TraitType="Disease" MappingType="Name" MappingValue="HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A" MappingRef="Preferred">
        <MedGen CUI="C0878676" Name="6-Pyruvoyl-tetrahydrobiopterin synthase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4987165" TraitType="Disease" MappingType="XRef" MappingValue="C0878676" MappingRef="MedGen">
        <MedGen CUI="C0878676" Name="6-Pyruvoyl-tetrahydrobiopterin synthase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

